Case Reports in Neurological Medicine

Case Reports in Neurological Medicine / 2019 / Article

Case Report | Open Access

Volume 2019 |Article ID 7615605 |

Jesus Eduardo Garcia-Berlanga, Mariana Moscovich, Isaac Jair Palacios, Alejandro Banegas-Lagos, Augusto Rojas-Martinez, Daniel Martinez-Ramirez, "CAPN1 Variants as Cause of Hereditary Spastic Paraplegia Type 76", Case Reports in Neurological Medicine, vol. 2019, Article ID 7615605, 5 pages, 2019.

CAPN1 Variants as Cause of Hereditary Spastic Paraplegia Type 76

Academic Editor: Federico Micheli
Received03 May 2019
Accepted23 May 2019
Published01 Jul 2019


Background. Autosomal recessive hereditary spastic paraplegias (HSP) are a rare group of hereditary neurodegenerative disorders characterized by spasticity with or without other symptoms. SPG11 gene is the most common cause of autosomal recessive HSP. We report a case of autosomal recessive spastic paraplegia type 76 due to heterozygous variants of CAPN1 in an Argentinean subject. Case Presentation. A 38-year-old Argentinean female presented with progressive gait problems and instability of 15-year duration. Oculomotor abnormalities, ataxia, bradykinesia, cervical dystonia, and lower limb pyramidal signs were observed. Brain MRI was unremarkable. Whole-exome sequencing analysis identified two heterozygous variants in CAPN1. Conclusions. Clinicians should screen for CAPN1 mutation in a young female patient without significant family history with a spastic paraplegia syndrome associated with other symptoms.

1. Background

Hereditary spastic paraplegias (HSP) are a group of heterogeneous degenerative disorders characterized by lower limb spasticity and weakness due to progressive degeneration of corticospinal tracts [1]. HSP can present as a pure form only with pyramidal symptoms, or as a complex form associated with other symptoms. HSP are transmitted in all modes of inheritance [2]. The autosomal dominant mode of inheritance is the most prevalent representing 70% of cases. Mutation in SPAST gene accounts for 40% of the autosomal dominant HSP. In the recessive HSP, the most frequent mutation is in SPG11. We report a case of autosomal recessive spastic paraplegia type 76 (SPG76, OMIM #616907) due to heterozygous variants of CAPN1 in an Argentinean subject.

2. Case Presentation

A 38-year-old Argentinean female presented with slowly progressive unsteadiness noticed first at age 23. She reported pronounced instability and gait problems as disease progressed. Her gait problems were described as short steps, with starting hesitation, fear of falling, and needing to hold from walls to avoid falling. She also reported several falls, dizziness, neck pain, and constipation. Symptoms progressed over the years affecting her mobility and functionality. She currently needs assistance for moving around. No relevant medical, family, or psychosocial history was reported. No past interventions were reported.

On neurological examination (Video 1), she presented dysarthria, interrupted slow horizontal and vertical eye movements, and slow horizontal saccades. She manifested spasticity and hyperreflexia more pronounced in her lower extremities. Mild cervical dystonia with bradykinesia was also observed. She showed ataxic symptoms more pronounced on her left upper extremity. Gait was spastic and no cognitive abnormalities were observed.

Brain MRI with and without contrast was unremarkable. Due to the presence of a slowly progressive adult onset spastic-ataxia syndrome, associated with other neurological abnormalities, and facing the challenge of poor financial access, we decided to optimize our resources studying the patient using whole-exome sequencing (CentoDX™, Centogene AG, Germany). The analysis identified two variants in CAPN1 (MIM:114220) considered as probably pathogenic Class 2, according to the American College of Medical Genetics and Genomics criteria. She was heterozygous for a splicing mutation in intron 16 (c.1729+1G>A) and a second splicing mutation in intron 12 (c.1353+2T>C). Carrier testing in the parents was not performed. Due to the strong phenotypic overlap between the symptoms and previously reported cases, we consider the detected variants as pathogenic of SPG76.

3. Discussion

We report two pathogenic variants of CAPN1 gene and the first case affecting two noncoding regions (introns) in a Latin-American patient. Table 1 describes all SPG76 reported cases in the literature [3, 4]. We observed that female patients are more commonly (67%) affected, with a mean age of onset of 19.8 years (Min. = 5, Max. = 39), most had family history of consanguinity (71%), and most were homozygous (77%). All initiated with lower limb spasticity, 85% reported upper limb spasticity, 58% showed ataxia, and 41% reported dysarthria. Our case also presented with oculomotor abnormalities. Three cases showed cerebellar atrophy and 1 spinal atrophy on MRI.

EthnicityAge at onsetAge at diagnosisGenderLower limbs spasticityUpper limbs spasticityAtaxiaDysarthriaOculomotor ImpairmentExon or Intron affectedMutationTypeHeterozygous /HomozygousConsanguinityBrain MRINCS and SSEP

1Latin AmericanNANANA++----c.1176G>A
Stop gain mutationHomozygous+NANA

2Latin AmericanNANANA++----c.1176G>A

3Latin AmericanNANANA++----c.1176G>A

4Latin American2237F++----c.1176G>A

Novel LoF MutationHomozygous-NANA

Novel LoF MutationHomozygous-NANA

7Latin American3042F+++---c.1176G>A
LoF MutationHeterozygous+NANA

8Latin American38-M+++---c.1176G>A
LoF MutationHomozygous+NANA

LoF MutationHomozygous+NANormal

LoF MutationHomozygous+NANA

LoF MutationHomozygous+NANA

Stop variantHomozygous+NAModerate Sensory Axonal Neuropathy

Stop variantHomozygous+NAModerate Sensory Axonal Neuropathy

Stop variantHomozygous+NormalNA

Stop variantHomozygous+NANA

Stop variantHomozygous+NANA

Stop variantHomozygous+NANA

Stop variantHomozygous+NANA


DeletionHeterozygous-Atrophy of spinal cordNA

21Caucasian1922F+++--Ex:4c.1605+5G>AMutation SplicingHeterozygous-NormalNA

22Indian3343F++++-Ex:3c.337+1G>ASplice MutationHomozygous+Mild cerebellar atrophyNormal

23IndianNANAFNANANANANAEx:3c.337+1G>ASplice MutationHomozygous+NANA

24Caucasian2939F+++++Ex:6c.759+1G>ADonor splice siteHomozygous+Mild cerebellar vermal atrophyNA

25Caucasian3337F++++-Ex:6c.759+1G>ADonor splice siteHomozygous+NANA



28Arab3054F++++-Ex10c. 1176G>A
p. Trp392
Nucleotide substitutionHeterozygous+NormalNormal

29Arab1530F++++-Ex:10c. 1176G>A
p. Trp392
Nucleotide substitutionHeterozygous+NormalNormal

30Asian3742F+++---c.2118+1G>TDonor Splice siteHomozygousNANANA


32Caucasian2020F+-----c.397C>TMutation in DYSFHomozygous+NANA

33Asian3737M+++---c.843+1G>CDonor Splice SiteHomozygous+NANA

34Caucasian1314F+++--Ex: 13c.1534C>T
NAHomozygous-Small midbrain and ponds, cerebellar atrophyDelayed cortical wave defective conduction of large sensory fibers

35 (our case)Latin American2338F+++++In: 12 and 16c.1729+1G>A
Donor Splice MutationHeterozygousNANormalNA

Abbreviations. F: female, M: male, +: present, -: absent, LoF: loss of function, DYSF: dysferlin, MRI: magnetic resonance image, C: cerebral, S: spinal, NCS: nerve conduction studies, SSEP: somatosensory evoked potentials, NA: not available.

In comparison with other published cases, we found similarities in that all of them presented lower limb spasticity and ataxia. The difference from our case was the oculomotor abnormalities, which was also reported in only one other case [5]. We suggest that the combined phenotype of spasticity and ataxia with oculomotor abnormalities, in a young female patient of Arab origin, could be a diagnostic clue for SPG76. The age of onset of our case was similar to that previously reported. All of the subjects experienced pronounced instability and gait problems as disease progresses [6].

CAPN1 mutations account for 2.2% of autosomal recessive HSP. CAPN1 is located in chromosome 11q13 and encodes calpain 1, a calcium-activated cysteine protease that is widely present in the central nervous system. The exact role of calpain 1 in humans is unclear; however, studies in animal models suggest that calpain 1 is involved in synaptic plasticity, neuronal migration, neuronal necrosis, and maintenance [7].

4. Conclusions

Our report adds to the clinical and genetical spectrum of CAPN1-related SPG76 disorders. We recommend clinicians to consider screening for CAPN1 in a young female patient with spastic paraplegia with additional neurological symptoms without significant family history.


HSP:Hereditary spastic paraplegia
SPAST:Spastin gene
SPG:Spastic paraplegia gene
CAPN1:Calpain 1 gene
MRI:Magnetic resonance imaging.

Data Availability

All data generated or analyzed during the case report are included in the published article.

Written informed consent was obtained from the patient for publication of this case report and any accompanying images or videos.

Conflicts of Interest

The authors report no financial or nonfinancial conflicts of interest.

Authors’ Contributions

Daniel Martinez-Ramirez and Jesus Eduardo Garcia-Berlanga were responsible for conception, organization, and execution. All the authors were responsible for the preparation of the manuscript: writing of the first draft, review and critique, and reading and approving the final version of the manuscript.


We would like to thank the patient for authorizing us to use her clinical data to make it available for the medical community.

Supplementary Materials

Video Legends: We can observe interrupted slow horizontal and vertical eye movements with slow horizontal saccades. She had spasticity and hyperreflexia more pronounced in lower extremities. She also showed bilateral Hoffman and Trömner signs, with clonus in lower extremities, and presence of Babinski sign bilaterally. She presented cervical dystonia with laterocollis to the left, and mild bradykinesia was observed during rapid movements. Finger to nose test showed dyssynergia and hypometric movements, rapid alternating movements with dysdiadochokinesia, past pointing, and finger chasing with dyssynergia and dysmetria more pronounced on left upper extremity. Gait was spastic type with scissoring legs. (Supplementary Materials)


  1. C. Blackstone, “Hereditary spastic paraplegia,” Handbook of Clinical Neurology, vol. 148, pp. 633–652, 2018. View at: Google Scholar
  2. J. Finsterer, W. Löscher, S. Quasthoff, J. Wanschitz, M. Auer-Grumbach, and G. Stevanin, “Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance,” Journal of the Neurological Sciences, vol. 318, no. 1-2, pp. 1–18, 2012. View at: Publisher Site | Google Scholar
  3. J. Lambe, B. Monaghan, T. Munteanu, and J. Redmond, “CAPN1 mutations broadening the hereditary spastic paraplegia/spinocerebellar ataxia phenotype,” Practical Neurology, vol. 18, no. 5, pp. 369–372, 2018. View at: Publisher Site | Google Scholar
  4. C. Kocoglu, A. Gundogdu, G. Kocaman et al., “Homozygous CAPN1 mutations causing a spastic-ataxia phenotype in 2 families,” Neurology: Genetics, vol. 4, no. 1, p. e218, 2018. View at: Google Scholar
  5. Z. Gan-Or, N. Bouslam, N. Birouk et al., “Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia,” American Journal of Human Genetics, vol. 98, no. 6, p. 1271, 2016. View at: Publisher Site | Google Scholar
  6. F. Peng, Y. Sun, C. Quan, J. Wang, and J. Wu, “Two novel homozygous mutations of CAPN1 in Chinese patients with hereditary spastic paraplegia and literatures review,” Orphanet Journal of Rare Diseases, vol. 14, no. 1, p. 83, 2019. View at: Publisher Site | Google Scholar
  7. M. Baudry and X. Bi, “Calpain-1 and calpain-2: the yin and yang of synaptic plasticity and neurodegeneration,” Trends in Neurosciences, vol. 39, no. 4, pp. 235–245, 2016. View at: Publisher Site | Google Scholar

Copyright © 2019 Jesus Eduardo Garcia-Berlanga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.